Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody developed through the immortalization of human B lymphocytes targeted against the LPS O polysaccharide of P. aeruginosa serotype O11 [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody developed through the immortalization of human B lymphocytes targeted against the LPS O polysaccharide of P. aeruginosa serotype O11 [1]. |
Molecular Weight | N/A |
CAS No. | 885053-97-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Panobacumab 885053-97-4 inhibitor inhibit